BACKGROUND: Given the high-risk nature and nurse sensitivity of chemotherapy infusion and extravasation prevention, as well as the absence of an industry benchmark, a group of nurses studied oncology-specific nursing-sensitive indicators. . OBJECTIVES: The purpose was to establish a benchmark for the incidence of chemotherapy extravasation with vesicants, irritants, and irritants with vesicant potential. . METHODS: Infusions with actual or suspected extravasations of vesicant and irritant chemotherapies were evaluated. Extravasation events were reviewed by type of agent, occurrence by drug category, route of administration, level of harm, follow-up, and patient referrals to surgical consultation. . FINDINGS: A total of 739,812 infusions were evaluated, with 673 extravasation events identified. Incidence for all extravasation events was 0.09%.
BACKGROUND: Given the high-risk nature and nurse sensitivity of chemotherapy infusion and extravasation prevention, as well as the absence of an industry benchmark, a group of nurses studied oncology-specific nursing-sensitive indicators. . OBJECTIVES: The purpose was to establish a benchmark for the incidence of chemotherapy extravasation with vesicants, irritants, and irritants with vesicant potential. . METHODS: Infusions with actual or suspected extravasations of vesicant and irritant chemotherapies were evaluated. Extravasation events were reviewed by type of agent, occurrence by drug category, route of administration, level of harm, follow-up, and patient referrals to surgical consultation. . FINDINGS: A total of 739,812 infusions were evaluated, with 673 extravasation events identified. Incidence for all extravasation events was 0.09%.
Entities:
Keywords:
cancer program quality; chemotherapy; extravasation; irritant; venous access; vesicant
Authors: Terence Z Wong; Thad Benefield; Shane Masters; Jackson W Kiser; James Crowley; Dustin Osborne; Osama Mawlawi; James Barnwell; Pawan Gupta; Akiva Mintz; Kelley A Ryan; Steven R Perrin; Ronald K Lattanze; David W Townsend Journal: J Nucl Med Technol Date: 2019-06-10
Authors: Silvia Manrique-Rodríguez; Irene Heras-Hidalgo; M Sagrario Pernia-López; Ana Herranz-Alonso; M Camino Del Río Pisabarro; M Belén Suárez-Mier; M Antonia Cubero-Pérez; Verónica Viera-Rodríguez; Noemí Cortés-Rey; Elizabeth Lafuente-Cabrero; M Carmen Martínez-Ortega; Esther Bermejo-López; Cristina Díez-Sáenz; Piedad López-Sánchez; M Luisa Gaspar-Carreño; Rubén Achau-Muñoz; Juan F Márquez-Peiró; Marta Valera-Rubio; Esther Domingo-Chiva; Irene Aquerreta-González; Ignacio Pellín Ariño; M Cruz Martín-Delgado; Manuel Herrera-Gutiérrez; Federico Gordo-Vidal; Pedro Rascado-Sedes; Emilio García-Prieto; Lucas J Fernández-Sánchez; Sara Fox-Carpentieri; Carlos Lamela-Piteira; Luis Guerra-Sánchez; Miguel Jiménez-Aguado; María Sanjurjo-Sáez Journal: Drugs R D Date: 2020-12-21